Weight-normalized norepinephrine dosing and apparent BMI-dependent vasopressin responsiveness - Top-Institutions - MDSpire

Weight-normalized norepinephrine dosing and apparent BMI-dependent vasopressin responsiveness

  • By

  • Pedro D. Wendel-Garcia

  • Sebastian Morales

  • Paulo Melo

  • Greta Emilia Kiavialaitis

  • Peter Wohlrab

  • Ricardo Castro

  • Edda Tschernko

  • Glenn Hernández

  • Eduardo Kattan

  • April 14, 2026

  • 0 min

Share

Top Institutions in Endocrinology

Brief introduction explaining scope and methodology.

  • #1

    Johns Hopkins University School of Medicine
    Johns Hopkins University School of Medicine

    Baltimore, MD

    Key Differentiators

    • Critical Care Medicine
    • Pharmacology
    • Sepsis Research

  • #2

    Mayo Clinic
    Mayo Clinic

    Rochester, MN

    Key Differentiators

    • Critical Care Medicine
    • Clinical Pharmacology
    • Obesity Medicine

  • #3

    Massachusetts General Hospital (MGH)
    Massachusetts General Hospital (MGH)

    Boston, MA

    Key Differentiators

    • Critical Care Medicine
    • Pharmacokinetics
    • Sepsis Research

  • #4

    University of California, San Francisco (UCSF)
    University of California, San Francisco (UCSF)

    San Francisco, CA

    Key Differentiators

    • Critical Care Medicine
    • Clinical Pharmacology
    • Sepsis and Shock Research

  • #5

    Cleveland Clinic
    Cleveland Clinic

    Cleveland, OH

    Key Differentiators

    • Critical Care Medicine
    • Pharmacology
    • Obesity Research

Original Source(s)

Weight-normalized norepinephrine dosing and apparent BMI-dependent vasopressin responsiveness

  • by Pedro D. Wendel-Garcia, Sebastian Morales, Paulo Melo, Greta Emilia Kiavialaitis, Peter Wohlrab, Ricardo Castro, Edda Tschernko, Glenn Hernández, Eduardo Kattan

  • April 14, 2026

Related Content

Adipokine profiles and genetic variants of leptin receptor, adiponectin, and ghrelin pathways in obesity: prospective 12-month outcomes after bariatric interventions

Impact of body mass index on outcomes of cardiac rehabilitation: a systematic review and meta-analysis

After the Prescription: The Clinical Support Gap in Telehealth-Based GLP-1 Care